EichorEICHOR
Location: Tustin Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Tustin

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Solace Clinical Research - Tustin- Site Number : 8400020 · Sanofi · NCT07190196A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Phase 2 · Research Site 126 · Locus Biosciences · NCT05488340A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Phase 2 · Solace Clinical Research · Crystalys Therapeutics · NCT07535034A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients
Phase 2 · Solace Clinical Research - Populace Health (Network) · Elevara Medicines Limited · NCT07409103Establishing Normative Urodynamics Parameters for the Glean Urodynamics System in Healthy Adults
NA · Prestige Medical Group · Bright Uro · NCT07485205A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
NA · Prestige Medical Group · Rivermark Medical · NCT06849258A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Sub
Phase 1 · Solace Research /ID# 279155 · AbbVie · NCT07607964Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects
Phase 2 · Prestige Medical Group · Vaneltix Pharma, Inc. · NCT05737121Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Stud
Phase 2 · Artiva Investigational Site Tustin · Artiva Biotherapeutics, Inc. · NCT06991114Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Phase 3 · Ambros Clinical Trial Site · Ambros Therapeutics, Inc. · NCT07210515A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Phase 3 · University Clinical Investigators, Inc. · Eli Lilly and Company · NCT07392190A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Phase 3 · University Clinical Investigators, Inc. · Pfizer · NCT07595549A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary
Phase 2 · Research Site · AstraZeneca · NCT07082738A Study of RSLV-132 in Females With Sjögren's Disease
Phase 2 · Resolve Clinical Site · Resolve Therapeutics · NCT06440525MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Foothill Reg Med Ctr · Stryker Instruments · NCT03072927Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syn
Phase 2 · Prestige Medical Group · Vaneltix Pharma, Inc. · NCT06394830A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
Phase 2 · University Clinical Investigators, Incorporated · Pfizer · NCT07575932A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Phase 3 · Orange County Research Center · Boehringer Ingelheim · NCT06424288Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
Phase 1 · Orange County Research Center · Vir Biotechnology, Inc. · NCT05484206A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Phase 3 · Solace Clinical Research California · Janssen Research & Development, LLC · NCT07438496A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Adm
Phase 3 · Solace Clinical Research · Amgen · NCT07388498A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Phase 3 · Prestige Medical Group · Eli Lilly and Company · NCT07202884A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Phase 3 · University Clinical Investigators, Inc. · Eli Lilly and Company · NCT07321886A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Phase 1/Phase 2 · Nkarta Investigational Site · Nkarta, Inc. · NCT06557265A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insuli
Phase 3 · University Clin Investigators · Novo Nordisk A/S · NCT07076199
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.